UroCor, Zeneca Pharmaceuticals deal

UCOR will co-promote Zeneca's Zoladex and Casodex prostate cancer

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE